LATEST NEWS
- Institute News
Antibody therapeutics will likely be a critical tool for protecting frontline healthcare workers and those at most risk of SARS-CoV-2 infection
- Research News
New research gives further evidence that autoimmunity plays a role in Parkinson’s disease
- Institute News
To aid vaccine design, researchers will investigate how a diverse population fights off viral attack
- Research News
Newly discovered biological switch evolved to stimulate the immune system—can also lead to immune paralysis
- Research News
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates
- Institute News
Former AMCC Chair and CEO David M. Rickey joins Institute Board
- Institute News
Foley & Lardner partner J. Mark Waxman joins Institute Board
- Institute News
The proposed iMAP will reveal new targets for immunotherapy, and may lead to a new wave of medicines and vaccines that can prevent heart attacks and strokes; La Jolla Institute for Immunology researcher Klaus Ley and Scripps researcher Eric Topol are key members of the iMAP team.
- Institute News
Sometimes it takes a personal health crisis to galvanize people to pursue a life-changing path they could have never envisioned.
- Research News
The finding is important to both the basic understanding of this disease—the world’s most common mosquito-borne illness—and to the hunt for an effective vaccine for dengue.
- Institute News
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
